Post-treatment with Meloxicam Attenuates MPP+-Induced Neurotoxicity via PI3K/Akt-Dependent Maintenance of Mcl-1.
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the nigrostriatal pathway. Current treatments for PD primarily provide symptomatic relief through dopamine replacement; however, no neuroprotective drugs are currently clinically available. Our prev...